Acute management of propionic acidemia

Molecular Genetics and Metabolism

Volumn 105, Issue 1, 2012, Pages 16-25

  Chapman, Kimberly A ^a   Gropman, Andrea ^a   MacLeod, Erin ^a   Stagni, Kathy ^b   Summar, Marshall L ^a   Ueda, Keiko ^c   Mew, Nicholas Ah ^a   Franks, Jill ^d   Island, Eddie ^e   Matern, Dietrich ^f   Pena, Loren ^g   Smith, Brittany ^d   Sutton, V Reid ^h   Urv, Tiina ⁱ   Venditti, Charles ⁱ   Chakrapani, Anupam ^j  

^a CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

^b Organic Acidemia Association   (United States)

^c TUFTS MEDICAL CENTER   (United States)

^d Propionic Acidemia Foundation   (United States)

^e GEORGETOWN UNIVERSITY   (United States)

^f MAYO CLINIC   (United States)

^g UNIVERSITY OF ILLINOIS   (United States)

^h TEXAS CHILDREN S HOSPITAL   (United States)

ⁱ NATIONAL INSTITUTES OF HEALTH   (United States)

^j BIRMINGHAM CHILDREN S HOSPITAL   (United Kingdom)

more..

Author keywords

Acute management; Inborn error of metabolism; Organic acidemia; Propionic acidemia; Treatment

Indexed keywords

BENZOIC ACID PLUS PHENYLACETIC ACID; CARGLUMIC ACID; CARNITINE; GLUCOSE; INTRALIPID; METRONIDAZOLE; SENOKOT;

ADD ON THERAPY; ARTIFICIAL VENTILATION; CATABOLISM; CLINICAL EVALUATION; COMA; CONFERENCE PAPER; DEATH; EXTRACORPOREAL OXYGENATION; HOSPITAL DISCHARGE; HUMAN; INTENSIVE CARE; LETHARGY; MORTALITY; PRIORITY JOURNAL; PROPIONIC ACIDEMIA; TREATMENT INDICATION; UNITED STATES; VOMITING;

HEALTH PLANNING GUIDELINES; HUMANS; PROPIONIC ACIDEMIA;

EID: 84855355358     PISSN: 10967192     EISSN: 10967206     Source Type: Journal    
DOI: 10.1016/j.ymgme.2011.09.026     Document Type: Conference Paper

References (53)

1. Prietsch V., Lindner M., Zschocke J., Nyhan W.L., Hoffmann G.F. Emergency management of inherited metabolic diseases. J. Inherit. Metab. Dis. 2002, 25:531-546.
2. Saudubray J.M., Sedel F., Walter J.H. Clinical approach to treatable inborn metabolic diseases: an introduction. J. Inherit. Metab. Dis. 2006, 29:261-274.
3. Dixon M.A., Leonard J.V. Intercurrent illness in inborn errors of intermediary metabolism. Arch. Dis. Child. 1992, 67:1387-1391.
4. Kuhn P., Dheu C., Bolender C., Chognot D., Keller L., Demil H., Donato L., Langer B., Messer J., Astruc D. Incidence and distribution of pathogens in early-onset neonatal sepsis in the era of antenatal antibiotics. Paediatr. Perinat. Epidemiol. 2010, 24:479-487.
5. Kasper D.C., Ratschmann R., Metz T.F., Mechtler T.P., Moslinger D., Konstantopoulou V., Item C.B., Pollak A., Herkner K.R. The national austrian newborn screening program-eight years experience with mass spectrometry. past, present, and future goals. Wien. Klin. Wochenschr. 2010, 122:607-613.
6. Moammar H., Cheriyan G., Mathew R., Al-Sannaa N. Incidence and patterns of inborn errors of metabolism in the Eastern Province of Saudi Arabia, 1983-2008. Ann. Saudi Med. 2010, 30:271-277.
7. Niu D.M., Chien Y.H., Chiang C.C., Ho H.C., Hwu W.L., Kao S.M., Chiang S.H., Kao C.H., Liu T.T., Chiang H., Hsiao K.J. Nationwide survey of extended newborn screening by tandem mass spectrometry in Taiwan. J. Inherit. Metab. Dis. 2010, 33:S295-S305.
8. Bhan A.K., Brody C. Propionic acidemia: a rare cause of cardiomyopathy. Congest. Heart Fail. 2001, 7:218-219.
9. Bultron G., Seashore M.R., Pashankar D.S., Husain S.Z. Recurrent acute pancreatitis associated with propionic acidemia. J. Pediatr. Gastroenterol. Nutr. 2008, 47:370-371.
10. Delgado C., Macias C., de la Sierra Garcia-Valdecasas, Perez M., del Portal L.R., Jimenez L.M. Subacute presentation of propionic acidemia. J. Child Neurol. 2007, 22:1405-1407.
11. Nyhan W.L., Bay C., Beyer E.W., Mazi M. Neurologic nonmetabolic presentation of propionic acidemia. Arch. Neurol. 1999, 56:1143-1147.
12. Field J.M., Hazinski M.F., Sayre M.R., Chameides L., Schexnayder S.M., Hemphill R., Samson R.A., Kattwinkel J., Berg R.A., Bhanji F., Cave D.M., Jauch E.C., Kudenchuk P.J., Neumar R.W., Peberdy M.A., Perlman J.M., Sinz E., Travers A.H., Berg M.D., Billi J.E., Eigel B., Hickey R.W., Kleinman M.E., Link M.S., Morrison L.J., O'Connor R.E., Shuster M., Callaway C.W., Cucchiara B., Ferguson J.D., Rea T.D., Vanden Hoek T.L. Part 1: executive summary: 2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Circulation 2010, 122:S640-S656.
13. Hazinski M.F., Nolan J.P., Billi J.E., Bottiger B.W., Bossaert L., de Caen A.R., Deakin C.D., Drajer S., Eigel B., Hickey R.W., Jacobs I., Kleinman M.E., Kloeck W., Koster R.W., Lim S.H., Mancini M.E., Montgomery W.H., Morley P.T., Morrison L.J., Nadkarni V.M., O'Connor R.E., Okada K., Perlman J.M., Sayre M.R., Shuster M., Soar J., Sunde K., Travers A.H., Wyllie J., Zideman D. Part 1: executive summary: 2010 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science with treatment recommendations. Circulation 2010, 122:S250-S275.
14. Tsalikian E., Simmons P., Gerich J.E., Howard C., Haymond M.W. Glucose production and utilization in children with glycogen storage disease type I. Am. J. Physiol. 1984, 247:E513-E519.
15. Yannicelli S., Acosta P.B., Velazquez A., Bock H.G., Marriage B., Kurczynski T.W., Miller M., Korson M., Steiner R.D., Rutledge L., Bernstein L., Chinsky J., Galvin-Parton P., Arnold G.L. Improved growth and nutrition status in children with methylmalonic or propionic acidemia fed an elemental medical food. Mol. Genet. Metab. 2003, 80:181-188.
16. Holliday M.A., Segar W.E. The maintenance need for water in parenteral fluid therapy. Pediatrics 1957, 19:823-832.
17. Feillet F., Bodamer O.A., Dixon M.A., Sequeira S., Leonard J.V. Resting energy expenditure in disorders of propionate metabolism. J. Pediatr. 2000, 136:659-663.
18. Coss-Bu J.A., Klish W.J., Walding D., Stein F., Smith E.O., Jefferson L.S. Energy metabolism, nitrogen balance, and substrate utilization in critically ill children. Am. J. Clin. Nutr. 2001, 74:664-669.
19. Henriquez H., el Din A., Ozand P.T., Subramanyam S.B., al Gain S.I. Emergency presentations of patients with methylmalonic acidemia, propionic acidemia and branched chain amino acidemia (MSUD). Brain Dev. 1994, 16:86-93. Suppl.
20. Ozand P.T., Devol E.B., Gascon G.G. Neurometabolic diseases at a national referral center: five years experience at the King Faisal Specialist Hospital and Research Centre. J. Child Neurol. 1992, 7(Suppl):S4-S11.
21. Al Essa M., Rahbeeni Z., Jumaah S., Joshi S., Al Jishi E., Rashed M.S., Al Amoudi M., Ozand P.T. Infectious complications of propionic acidemia in Saudia Arabia. Clin. Genet. 1998, 54:90-94.
22. Werlin S.L. E. coli sepsis as a presenting sign in neonatal propionic acidemia. Am. J. Med. Genet. 1993, 46:455-456.
23. Ah Mew N., McCarter R., Daikhin Y., Nissim I., Yudkoff M., Tuchman M. N-carbamylglutamate augments ureagenesis and reduces ammonia and glutamine in propionic acidemia. Pediatrics 2010, 126:e208-e214.
24. Schwahn B.C., Pieterse L., Bisset W.M., Galloway P.G., Robinson P.H. Biochemical efficacy of N-carbamylglutamate in neonatal severe hyperammonaemia due to propionic acidaemia. Eur. J. Pediatr. 2010, 169:133-134.
25. Biggemann B., Zass R., Wendel U. Postoperative metabolic decompensation in maple syrup urine disease is completely prevented by insulin. J. Inherit. Metab. Dis. 1993, 16:912-913.
26. Wendel U., Langenbeck U., Lombeck I., Bremer H.J. Maple syrup urine disease-therapeutic use of insulin in catabolic states. Eur. J. Pediatr. 1982, 139:172-175.
27. Cooke D.W., Plotnick L. Management of diabetic ketoacidosis in children and adolescents. Pediatr. Rev. 2008, 29:431-435.
28. Coude F.X., Sweetman L., Nyhan W.L. Inhibition by propionyl-coenzyme A of N-acetylglutamate synthetase in rat liver mitochondria. A possible explanation for hyperammonemia in propionic and methylmalonic acidemia. J. Clin. Invest. 1979, 64:1544-1551.
29. Coude F.X., Ogier H., Grimber G., Parvy P., Pham Dinh D., Charpentier C., Saudubray J.M. Correlation between blood ammonia concentration and organic acid accumulation in isovaleric and propionic acidemia. Pediatrics 1982, 69:115-117.
30. Summar M., Pietsch J., Deshpande J., Schulman G. Effective hemodialysis and hemofiltration driven by an extracorporeal membrane oxygenation pump in infants with hyperammonemia. J. Pediatr. 1996, 128:379-382.
31. Al-Hassnan Z.N., Boyadjiev S.A., Praphanphoj V., Hamosh A., Braverman N.E., Thomas G.H., Geraghty M.T. The relationship of plasma glutamine to ammonium and of glycine to acid-base balance in propionic acidaemia. J. Inherit. Metab. Dis. 2003, 26:89-91.
32. Filipowicz H.R., Ernst S.L., Ashurst C.L., Pasquali M., Longo N. Metabolic changes associated with hyperammonemia in patients with propionic acidemia. Mol. Genet. Metab. 2006, 88:123-130.
33. Wolff J.A., Carroll J.E., Le Phuc Thuy, Prodanos C., Haas R., Nyhan W.L. Carnitine reduces fasting ketogenesis in patients with disorders of propionate metabolism. Lancet 1986, 1:289-291.
34. Chalmers R.A., Roe C.R., Stacey T.E., Hoppel C.L. Urinary excretion of l-carnitine and acylcarnitines by patients with disorders of organic acid metabolism: evidence for secondary insufficiency of l-carnitine. Pediatr. Res. 1984, 18:1325-1328.
35. Di Donato S., Rimoldi M., Garavaglia B., Uziel G. Propionylcarnitine excretion in propionic and methylmalonic acidurias: a cause of carnitine deficiency. Clin. Chim. Acta. 1984, 139:13-21.
36. Evans A.M., Fornasini G. Pharmacokinetics of l-carnitine. Clin. Pharmacokinet. 2003, 42:941-967.
37. Kurczynski T.W., Hoppel C.L., Goldblatt P.J., Gunning W.T. Metabolic studies of carnitine in a child with propionic acidemia. Pediatr. Res. 1989, 26:63-66.
38. Roe C.R., Millington D.S., Maltby D.A., Bohan T.P., Hoppel C.L. l-carnitine enhances excretion of propionyl coenzyme A as propionylcarnitine in propionic acidemia. J. Clin. Invest. 1984, 73:1785-1788.
39. Rebouche C.J. Kinetics, pharmacokinetics, and regulation of l-carnitine and acetyl-l-carnitine metabolism. Ann. N. Y. Acad. Sci. 2004, 1033:30-41.
40. Protein and Amino Acid Requirements in Human Nutrition 2007, United Nations University, Geneva.
41. Brandt I.K., Hsia Y.E., Clement D.H., Provence S.A. Propionicacidemia (ketotic hyperglycinemia): dietary treatment resulting in normal growth and development. Pediatrics 1974, 53:391-395.
42. Kahler S.G., Millington D.S., Cederbaum S.D., Vargas J., Bond L.D., Maltby D.A., Gale D.S., Roe C.R. Parenteral nutrition in propionic and methylmalonic acidemia. J. Pediatr. 1989, 115:235-241.
43. Walter J.H., Leonard J.V., Thompson G.N., Halliday D. Parenteral nutrition in propionic acidemia and methylmalonic acidemia. J. Pediatr. 1990, 117:338-339.
44. Anderson T.L., Muttart C.R., Bieber M.A., Nicholson J.F., Heird W.C. A controlled trial of glucose versus glucose and amino acids in premature infants. J. Pediatr. 1979, 94:947-951.
45. Thompson G.N., Walter J.H., Bresson J.L., Ford G.C., Lyonnet S.L., Chalmers R.A., Saudubray J.M., Leonard J.V., Halliday D. Sources of propionate in inborn errors of propionate metabolism. Metabolism 1990, 39:1133-1137.
46. Thompson G.N., Chalmers R.A., Walter J.H., Bresson J.L., Lyonnet S.L., Reed P.J., Saudubray J.M., Leonard J.V., Halliday D. The use of metronidazole in management of methylmalonic and propionic acidaemias. Eur. J. Pediatr. 1990, 149:792-796.
47. North K.N., Korson M.S., Gopal Y.R., Rohr F.J., Brazelton T.B., Waisbren S.E., Warman M.L. Neonatal-onset propionic acidemia: neurologic and developmental profiles, and implications for management. J. Pediatr. 1995, 126:916-922.
48. Leonard J.V., Walter J.H., McKiernan P.J. The management of organic acidaemias: the role of transplantation. J. Inherit. Metab. Dis. 2001, 24:309-311.
49. Deodato F., Boenzi S., Santorelli F.M., Dionisi-Vici C. Methylmalonic and propionic aciduria. Am. J. Med. Genet. C. Semin. Med. Genet. 2006, 142C:104-112.
50. Prasad C., Nurko S., Borovoy J., Korson M.S. The importance of gut motility in the metabolic control of propionic acidemia. J. Pediatr. 2004, 144:532-535.
51. Klein N.P., Aukes L., Lee J., Fireman B., Shapira S.K., Slade B., Baxter R., Summar M. Evaluation of immunization rates and safety among children with inborn errors of metabolism. Pediatrics 2011, 127:e1139-e1146.
52. Morgan T.M., Schlegel C., Edwards K.M., Welch-Burke T., Zhu Y., Sparks R., Summar M. Vaccines are not associated with metabolic events in children with urea cycle disorders. Pediatrics 2011, 127:e1147-e1153.
53. Goran M.I., Kaskoun M., Johnson R. Determinants of resting energy expenditure in young children. J. Pediatr. 1994, 125:362-367.